- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Sustainable Track Record
U.S. Pharmaceuticals & Biotech Sustainable Track Record
Results
13
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
13 companies
Exelixis
Market Cap: US$10.5b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$38.69
7D
-4.4%
1Y
47.4%
BioStem Technologies
Market Cap: US$85.1m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$5.08
7D
2.4%
1Y
-50.9%
CytomX Therapeutics
Market Cap: US$397.4m
Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.
CTMX
US$2.84
7D
39.2%
1Y
136.7%
Puma Biotechnology
Market Cap: US$237.7m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$4.70
7D
4.0%
1Y
83.6%
Merck
Market Cap: US$199.0b
Operates as a healthcare company worldwide.
MRK
US$77.60
7D
-4.8%
1Y
-31.4%
Catalyst Pharmaceuticals
Market Cap: US$2.4b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$19.13
7D
-6.2%
1Y
-4.1%
Harmony Biosciences Holdings
Market Cap: US$1.5b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$27.04
7D
-17.1%
1Y
-32.0%
ACADIA Pharmaceuticals
Market Cap: US$3.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$21.21
7D
-14.3%
1Y
37.0%
ADMA Biologics
Market Cap: US$3.7b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$15.32
7D
-5.2%
1Y
-21.2%
Medpace Holdings
Market Cap: US$14.0b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$487.95
7D
-2.8%
1Y
49.6%
Halozyme Therapeutics
Market Cap: US$8.8b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
HALO
US$73.97
7D
-3.5%
1Y
29.9%
Eli Lilly
Market Cap: US$666.0b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$714.59
7D
-6.3%
1Y
-21.4%
Earth Science Tech
Market Cap: US$51.2m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.17
7D
-9.1%
1Y
12.9%